DMAE (Dimethylaminoethanol) vs Ginkgo Biloba

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

DMAE (Dimethylaminoethanol)Ginkgo Biloba
CategoryNootropicsNootropics
Standard Dose150-400 mg/day (as DMAE bitartrate, typically 37% DMAE)120-240 mg/day of standardized extract (24% flavone glycosides, 6% terpene lactones) divided into 2-3 doses
TimingMorning. With or without food.With or without food. Split into 2-3 doses throughout the day. Effects may take 4-6 weeks to manifest.
Cycle DurationOngoing; no strict cycling requiredOngoing; no cycling required. Clinical trials typically run 22-26 weeks.
Evidence Levelanimal_plus_anecdotalstrong_human

Mechanism

Structural analog of choline that crosses the BBB more readily than choline itself. Paradoxically increases choline availability not by serving as a direct precursor to acetylcholine, but by inhibiting choline metabolism in peripheral tissues, thereby increasing circulating choline available for brain uptake. Also acts as a free radical scavenger and membrane stabilizer. Reduces lipofuscin accumulation in neuronal cells, an age pigment associated with cellular aging.

Standard Dosing

150-400 mg/day (as DMAE bitartrate, typically 37% DMAE)

Timing

Morning. With or without food.

Cycle Duration

Ongoing; no strict cycling required

Side Effects

  • Headache
  • Insomnia
  • Muscle tension
  • Overstimulation
  • GI discomfort
  • Vivid dreams

Contraindications

  • Pregnancy (potential teratogenic effects — inhibits choline incorporation into phospholipids critical for fetal neural development)
  • Bipolar disorder (may worsen depressive phase)
  • Epilepsy (may lower seizure threshold)

Best Stacking Partners

RacetamsPhosphatidylserineOmega-3 (DHA)
B

Ginkgo Biloba

Nootropics

Mechanism

Standardized extract (EGb 761) contains flavonoid glycosides (24%) and terpene lactones (6% — ginkgolides A/B/C and bilobalide) that act through multiple pathways: potent free radical scavenging and inhibition of membrane lipid peroxidation; antagonism of platelet-activating factor (PAF) via ginkgolides; enhancement of cerebral blood flow through nitric oxide-mediated vasodilation and reduced blood viscosity; and increased prefrontal dopamine and acetylcholine release via acylated flavonol glycosides. Bilobalide provides direct neuroprotection against excitotoxicity and mitochondrial dysfunction.

Standard Dosing

120-240 mg/day of standardized extract (24% flavone glycosides, 6% terpene lactones) divided into 2-3 doses

Timing

With or without food. Split into 2-3 doses throughout the day. Effects may take 4-6 weeks to manifest.

Cycle Duration

Ongoing; no cycling required. Clinical trials typically run 22-26 weeks.

Side Effects

  • Headache
  • GI distress
  • Dizziness
  • Allergic skin reactions
  • Increased bleeding risk

Contraindications

  • Bleeding disorders
  • Upcoming surgery (discontinue 2 weeks prior)
  • Seizure disorders (ginkgotoxin in poorly standardized extracts may lower seizure threshold)
  • Pregnancy (may increase bleeding risk)

Best Stacking Partners

VinpocetinePhosphatidylserineBacopa MonnieriPanax Ginseng

Buy these compounds

Fast buy links (we may earn a small commission at no extra cost).

Search DMAE (Dimethylaminoethanol) on Amazon →Search Ginkgo Biloba on Amazon →Search DMAE (Dimethylaminoethanol) on iHerb →Search Ginkgo Biloba on iHerb →

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →